Discover
ENSC
Ensysce Biosciences, Inc.
0.47
2 x 0.32
2 x 0.53
bid
ask
+
0.00
0.30%
2 @ 06:00 AM
0.46 -0.01 (3.04%)
| Ytd | -48.43% | |
| 1y | -77.62% |
0.46
day range
0.50
0.23
52 week range
2.75
| Open | 0.48 | Prev Close | 0.47 | Low | 0.46 | High | 0.50 | Mkt Cap | 9.23M |
| Vol | 664.44K | Avg Vol | 14.79M | EPS | -2.52 | P/E | N/A | Forward P/E | -9.08 |
| Beta | 0.97 | Short Ratio | 0.12 | Inst. Own | 22.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.35 | 200-d Avg | 0.58 | 1yr Est | 102.00 |
ENSC News
benzinga.com
Ensysce Biosciences Completes Enrollment In Final Stage Of PF614-MPAR-102 Clinical Study
~ ~ The Second Study Fully Enrolled for Breakthrough Therapy-Designated, First-in-Class Opioid Desig
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
benzinga.com
Ensysce Biosciences Q2 EPS $(0.20) Beats $(0.50) Estimate, Sales $1.164M Beat $1.000M Estimate
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.20) per share which beat the anal
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regu